Healthcare Pharmaceuticals Ltd.
Abemaciclib Cancer (oncology)
Originator: Verzenio · Eli Lilly and Company (Lilly USA, LLC)
| Brand | Strength | Form |
|---|---|---|
| Abezino | 150 mg and 200 mg tablets | — |
| Abezino | 150 mg | Tablet |
| Abezino | 200 mg | Tablet |
Adalimumab Immunology & rheumatology
Originator: Humira · AbbVie (originally developed and marketed by Abbott Laboratories; initial U.S. approval 2002)
| Brand | Strength | Form |
|---|---|---|
| Adalimab | 40 mg/0.8 ml | SC Injection |
Baricitinib Immunology & rheumatology
Originator: Olumiant · Eli Lilly and Company (co-developed with Incyte; initial U.S. approval 2018)
| Brand | Strength | Form |
|---|---|---|
| Baritinib | 2 mg | Tablet |
Bevacizumab Cancer (oncology)
Originator: Avastin · Genentech, Inc. / F. Hoffmann-La Roche Ltd
| Brand | Strength | Form |
|---|---|---|
| Bevacimab | 100 mg/4 mL and 400 mg/16 mL | — |
| Bevacimab | 400 mg/16 ml | IV Infusion |
| Bevacimab | 100 mg/4 ml | IV Infusion |
Empagliflozin Diabetes & metabolic
Originator: Jardiance · Boehringer Ingelheim, co-marketed with Eli Lilly and Company (licensed from Boehringer Ingelheim International GmbH)
| Brand | Strength | Form |
|---|---|---|
| Evania | 10 mg | Tablet |
| Evania | 25 mg | Tablet |
Insulin Glargine Diabetes & metabolic
Originator: Lantus · Sanofi
| Brand | Strength | Form |
|---|---|---|
| Abasaglar | 100 IU/ml | SC Injection |
Linagliptin Diabetes & metabolic
Originator: Tradjenta · Boehringer Ingelheim (marketed in the US by Boehringer Ingelheim Pharmaceuticals, Inc.; co-promoted with Eli Lilly in several markets)
| Brand | Strength | Form |
|---|---|---|
| Isentin | 5 mg | Tablet |
Osimertinib Cancer (oncology)
Originator: Tagrisso · AstraZeneca
| Brand | Strength | Form |
|---|---|---|
| Ositinib | 80 mg tablet | — |
| Ositinib | 80 mg | Tablet |
Rituximab Cancer (oncology)
Originator: Rituxan · Genentech, Inc. (a member of the Roche Group), with Biogen; Rituxan is jointly marketed by Biogen and Genentech USA in the US; MabThera is marketed by Roche
| Brand | Strength | Form |
|---|---|---|
| Recelbia | 10 mg/mL, 100 mg and 500 mg vials | — |
| Recelbia | 10 mg/ml | IV Infusion |
Sitagliptin Diabetes & metabolic
Originator: Januvia · Merck Sharp & Dohme (MSD), a subsidiary of Merck & Co., Inc.
| Brand | Strength | Form |
|---|---|---|
| Silinor | 100 mg | Tablet |
| Silinor | 50 mg | Tablet |
| Silinor | 25 mg | Tablet |
Sofosbuvir/Velpatasvir Antivirals (hepatitis C)
Originator: Epclusa · Gilead Sciences (Gilead Sciences Ireland UC for the EU)
| Brand | Strength | Form |
|---|---|---|
| Velatas | 400 mg + 100 mg tablet | — |
| Velatas | 400 mg+100 mg | Tablet |
Tofacitinib Immunology & rheumatology
Originator: Xeljanz / Xeljanz XR · Pfizer (initial U.S. approval 2012)
| Brand | Strength | Form |
|---|---|---|
| Jaknib | 5 mg | Tablet |
Trastuzumab Cancer (oncology)
Originator: Herceptin · Genentech, Inc. / F. Hoffmann-La Roche Ltd
| Brand | Strength | Form |
|---|---|---|
| Trazuma | 440 mg/20 mL | — |
| Trazuma | 440 mg/20 ml | IV Infusion |
Vildagliptin Diabetes & metabolic
Originator: Galvus · Novartis
| Brand | Strength | Form |
|---|---|---|
| Edvila | 50 mg | Tablet |
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.
